Citation 1:
    Title: Johnson & Johnson (JNJ) stock historical prices and data – Yahoo Finance
    URL: https://uk.finance.yahoo.com/quote/JNJ/history/?err_load=1#:~:text=16%20Apr%202025%20%20,9%2C943%2C900
    Location: chars 97–225

Citation 2:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=was%20approximately%20%24352%20billion
    Location: chars 295–441

Citation 3:
    Title: Johnson & Johnson (JNJ) stock historical prices and data – Yahoo Finance
    URL: https://uk.finance.yahoo.com/quote/JNJ/history/?err_load=1#:~:text=16%20Apr%202025%20%20,9%2C943%2C900
    Location: chars 442–570

Citation 4:
    Title: JNJ Economic Moat - Johnson & Johnson - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/jnj/qualitative/block/economic-moat#:~:text=Johnson%20%26%20Johnson%20possesses%20several,in%20a%20wide%20economic%20moat
    Location: chars 592–780

Citation 5:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=match%20at%20L1349%20ESG%20Risk,Rating%20ESG%20Risk%20Rating%20Assessment5
    Location: chars 799–980

Citation 6:
    Title: J&J sues to block Medicare drug price negotiations
    URL: https://www.axios.com/2023/07/18/johnson-johnson-files-lawsuit-ira#:~:text=Johnson%20%26%20Johnson%20,This%20legal%20move%20increases%20the
    Location: chars 981–1139

Citation 7:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=Capital%20Allocation%20Karen%20Andersen%2C%20CFA%2C,Director%2C%2027%20Sep%202024
    Location: chars 1170–1358

Citation 8:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=match%20at%20L1349%20ESG%20Risk,Rating%20ESG%20Risk%20Rating%20Assessment5
    Location: chars 1462–1643

Citation 9:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 2124–2291

Citation 10:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 2346–2513

Citation 11:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=Operational%20growth%20excluding%20COVID,various%20transactions%20throughout%20the%20year
    Location: chars 2565–2817

Citation 12:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,point
    Location: chars 2935–3104

Citation 13:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,general%20surgery%20robotic%20system%2C%20OTTAVA
    Location: chars 3501–3713

Citation 14:
    Title: Johnson & Johnson Operating Margin 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/operating-margin#:~:text=Johnson%20%26%20Johnson%27s%20biggest%20strength,offers%20products%20in%20the%20orthopedics
    Location: chars 3874–4077

Citation 15:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,19%20per%20share
    Location: chars 4284–4510

Citation 16:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Cash%20dividends%20paid%20were%20%244,share%20in%20fiscal%20year%202022
    Location: chars 4950–5129

Citation 17:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=The%20Company%20is%20organized%20into,and%20analysis%20of%20results%20of
    Location: chars 5360–5540

Citation 18:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=The%20Innovative%20Medicine%20segment%20is,arthritis%2C%20psoriatic%20arthritis%2C%20inflammatory%20bowel
    Location: chars 5683–5896

Citation 19:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=As%20previously%20announced%2C%20the%20Company,the%20third%20quarter%20of%202023
    Location: chars 6433–6722

Citation 20:
    Title: Johnson & Johnson Operating Margin 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/operating-margin#:~:text=Johnson%20%26%20Johnson%27s%20biggest%20strength,offers%20products%20in%20the%20orthopedics
    Location: chars 6723–6926

Citation 21:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=announced%20results%20for%20fourth,%E2%80%9D
    Location: chars 7076–7283

Citation 22:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,general%20surgery%20robotic%20system%2C%20OTTAVA
    Location: chars 7807–8019

Citation 23:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=announced%20results%20for%20fourth,%E2%80%9D
    Location: chars 8357–8564

Citation 24:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,point
    Location: chars 8809–8978

Citation 25:
    Title: Johnson & Johnson Operating Margin 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/operating-margin#:~:text=Johnson%20%26%20Johnson%27s%20biggest%20strength,offers%20products%20in%20the%20orthopedics
    Location: chars 9525–9728

Citation 26:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,general%20surgery%20robotic%20system%2C%20OTTAVA
    Location: chars 9836–10048

Citation 27:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=As%20previously%20announced%2C%20the%20Company,the%20third%20quarter%20of%202023
    Location: chars 10324–10613

Citation 28:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=announced%20results%20for%20fourth,%E2%80%9D
    Location: chars 10647–10854

Citation 29:
    Title: JNJ Economic Moat - Johnson & Johnson - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/jnj/qualitative/block/economic-moat#:~:text=Johnson%20%26%20Johnson%20possesses%20several,in%20a%20wide%20economic%20moat
    Location: chars 11016–11204

Citation 30:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Cash%20dividends%20paid%20were%20%244,share%20in%20fiscal%20year%202022
    Location: chars 11302–11481

Citation 31:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,of%20equity%20stake%20in%20Kenvue
    Location: chars 11539–11782

Citation 32:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,19%20per%20share
    Location: chars 11877–12103

Citation 33:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=the%20Company%20expects%20continued%20launches,impact%20the%20Company%E2%80%99s%20sales%20of
    Location: chars 12695–12895

Citation 34:
    Title: J&J sues to block Medicare drug price negotiations
    URL: https://www.axios.com/2023/07/18/johnson-johnson-files-lawsuit-ira#:~:text=Johnson%20%26%20Johnson%20,This%20legal%20move%20increases%20the
    Location: chars 13244–13402

Citation 35:
    Title: JNJ Economic Moat - Johnson & Johnson - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/jnj/qualitative/block/economic-moat#:~:text=Johnson%20%26%20Johnson%20possesses%20several,in%20a%20wide%20economic%20moat
    Location: chars 14514–14702

Citation 36:
    Title: JNJ Economic Moat - Johnson & Johnson - Alpha Spread
    URL: https://www.alphaspread.com/security/nyse/jnj/qualitative/block/economic-moat#:~:text=Johnson%20%26%20Johnson%20possesses%20several,in%20a%20wide%20economic%20moat
    Location: chars 15163–15351

Citation 37:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,point
    Location: chars 15847–16016

Citation 38:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=Operational%20growth%20excluding%20COVID,various%20transactions%20throughout%20the%20year
    Location: chars 16781–17033

Citation 39:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=the%20Company%20expects%20continued%20launches,impact%20the%20Company%E2%80%99s%20sales%20of
    Location: chars 17561–17761

Citation 40:
    Title: J&J sues to block Medicare drug price negotiations
    URL: https://www.axios.com/2023/07/18/johnson-johnson-files-lawsuit-ira#:~:text=Johnson%20%26%20Johnson%20,This%20legal%20move%20increases%20the
    Location: chars 17856–18014

Citation 41:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 18343–18510

Citation 42:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,19%20per%20share
    Location: chars 19009–19235

Citation 43:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=Capital%20Allocation%20Karen%20Andersen%2C%20CFA%2C,Director%2C%2027%20Sep%202024
    Location: chars 19378–19566

Citation 44:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Cash%20dividends%20paid%20were%20%244,share%20in%20fiscal%20year%202022
    Location: chars 19675–19854

Citation 45:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=,of%20the%20Company%E2%80%99s%20compensation%20programs
    Location: chars 20041–20204

Citation 46:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,of%20equity%20stake%20in%20Kenvue
    Location: chars 20205–20448

Citation 47:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=Capital%20Allocation%20Karen%20Andersen%2C%20CFA%2C,Director%2C%2027%20Sep%202024
    Location: chars 20789–20977

Citation 48:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2023 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Reports-Q4-and-Full-Year-2023-Results/#:~:text=,Full%20Year
    Location: chars 21949–22103

Citation 49:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 22104–22271

Citation 50:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=Adjusted%20Net%20Earnings,0.6
    Location: chars 22272–22464

Citation 51:
    Title: Johnson & Johnson Free Cash Flow 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/free-cash-flow#:~:text=Johnson%20%26%20Johnson%20Annual%20Free,17%2C728.00
    Location: chars 22465–22626

Citation 52:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2023 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Reports-Q4-and-Full-Year-2023-Results/#:~:text=,Full%20Year
    Location: chars 22710–22864

Citation 53:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 22865–23032

Citation 54:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Earnings%20before%20provision%20for%20taxes,16%2C370
    Location: chars 23088–23248

Citation 55:
    Title: Johnson & Johnson Free Cash Flow 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/free-cash-flow#:~:text=Johnson%20%26%20Johnson%20Annual%20Free,17%2C728.00
    Location: chars 23325–23486

Citation 56:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=match%20at%20L1349%20ESG%20Risk,Rating%20ESG%20Risk%20Rating%20Assessment5
    Location: chars 23621–23802

Citation 57:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=match%20at%20L566%20Our%20rating,generates%20close%20to%20one%20third
    Location: chars 24001–24177

Citation 58:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2024 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/investor-news/news-details/2025/Johnson--Johnson-Reports-Q4-and-Full-Year-2024-Results/default.aspx#:~:text=,4.3
    Location: chars 25697–25864

Citation 59:
    Title: Johnson & Johnson Reports Q4 and Full-Year 2023 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Reports-Q4-and-Full-Year-2023-Results/#:~:text=,Full%20Year
    Location: chars 26079–26233

Citation 60:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Earnings%20before%20provision%20for%20taxes,16%2C370
    Location: chars 26419–26579

Citation 61:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=the%20Company%20expects%20continued%20launches,impact%20the%20Company%E2%80%99s%20sales%20of
    Location: chars 26580–26780

Citation 62:
    Title: Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-final-results-of-exchange-offer-and-finalizes-separation-of-kenvue-inc#:~:text=NEW%20BRUNSWICK%2C%20N,day%20on%20August%2018%2C%202023
    Location: chars 27026–27251

Citation 63:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,of%20equity%20stake%20in%20Kenvue
    Location: chars 27540–27783

Citation 64:
    Title: Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2023/Johnson--Johnson-Announces-Updated-Financials-and-2023-Guidance-Following-Completion-of-the-Kenvue-Separation/default.aspx#:~:text=,19%20per%20share
    Location: chars 27784–28010

Citation 65:
    Title: Johnson & Johnson Free Cash Flow 2011-2025 | JNJ | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/JNJ/johnson-johnson/free-cash-flow#:~:text=Johnson%20%26%20Johnson%20Annual%20Free,17%2C728.00
    Location: chars 28196–28357

Citation 66:
    Title: J&J sues to block Medicare drug price negotiations
    URL: https://www.axios.com/2023/07/18/johnson-johnson-files-lawsuit-ira#:~:text=Johnson%20%26%20Johnson%20,This%20legal%20move%20increases%20the
    Location: chars 28545–28703

Citation 67:
    Title: Johnson & Johnson: Johnson & Johnson Earnings: Maintaining Our $164 FVE Despite Heavy Stelara Hit in 2025 | PDF | Johnson & Johnson | Investing
    URL: https://www.scribd.com/document/842236778/d1c273a6-492f-4935-a629-037176eb2d11#:~:text=match%20at%20L1349%20ESG%20Risk,Rating%20ESG%20Risk%20Rating%20Assessment5
    Location: chars 28809–28990

